Brought to you by WBIW News and Network Indiana

1340 AM, Saturday, November 21st, 2009

Lilly Drug Study Doesn't Turn Up Desired Results

Last updated on Monday, March 30, 2009
Advertisement

(INDIANAPOLIS) - Indianapolis-based Eli Lilly reports inconclusive phase II clinical trial results from an experimental drug to treat schizophrenia.

The study found the results from the experimental drug were no more effective than existing medication.

The company will conduct another trial next year and it "remains optimistic" in the experimental drug's promise as a future treatment.

669 patients enrolled in the study and 393 completed this four-week, in-patient trial.


Section navigation: Previous Article  |  Next Article  (Archives)

When you see news happening, tell us!
Call 812.275.7555  |  E-mail tips@wbiw.com  |  Or send an IM via your AOL, MSN or Yahoo Messenger to wbiwnews